Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Senescence and Influenza Vaccination
NCT01827462Phase 4Completed
- Sponsor
- Stanford University
- Start
- Oct 2007
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by Stanford University. Started Oct 2007; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01827462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01827462.